Biotech, Food & Drug

HB Ad Slot
HB Mobile Ad Slot

In today’s hyper-aware environment, concerns about food and drug safety are paramount for both companies and consumers.  The Food and Drug Administration (FDA) and the US Department of Agriculture (USDA) regulates the areas of biotech, food, and drug law. Additionally, laws including the 21st Century Cures Act, and cGMP (Current Good Manufacturing Processes), regulate industry standards/norms in food, cosmetics, and other industry-sectors. Visitors to the National Law Review will find the latest analysis of news, legislation, and upcoming cases/litigation as it relates to this area of law.

With researchers searching for new energy solutions and other developments in biotech, visitors to the NLR will have the opportunity to read content surrounding biosimilars, natural fuel production, medical devices, biotechnology, nanotechnology and materials, and the pharmaceuticals industry. Additionally, content relating to food and drug laws, limits on chemical use in cosmetic products, and other general health/safety topics are covered by the National Law Review and are updated regularly. Additionally, food safety and imports to the United States are also discussed as they become relevant. 

In addition to general health, science, and food/drug, the industry is also closely related to many of the issues related to intellectual property law. New applications for patents, intellectual property, licensing laws, and other areas which are governed by the PTAB court, often crossover into the industry.

New developments in legislation, including the legalization of recreational marijuana has created a new area ripe for legal analysis.  Regulations on how recreational marijuana can be advertised and marketed, distributed and the kind of insurance coverage necessary for dispensaries.  Additionally, employer drug-testing and marijuana statutes have been a hot area of litigation covered by the National Law Review.  

General practices in marketing standards, compliance of federal and state laws/legislation, licensing collaborations, and news related to bringing new products to the market, in the US and abroad, are among the areas visitors to NLR will read about daily. Drug pricing, changes in production standards, regulatory compliance, food safety and handling, drug laws (legalization of marijuana, both recreational and medicinal in the workplace), and labeling and nutritional requirements, are among the many topics covered by the National Law Review daily.

Visitors will always find the latest, up-to-date, most comprehensive coverage on the site. And, news and stories which affect the US, companies which are regulated in the industry, and multinational/international companies, are detailed regularly for NLR readers.

National Law Review Cannabis TwitterFor hourly updates on the latest news about biotech, food & drug, and cannabis laws, regulations, and legislation, be sure to follow our Cannabis X (formerly Twitter) feed, and sign up for complimentary e-news bulletins.

Recent Biotechnology, Food & Drug Administration FDA News

Title
Publication Date Organization Sort descending
Sep
22
2020
CMBG3 Attends MIT Event on Development of a COVID-19 Vaccine CMBG3 Law
Dec
10
2021
Prop 65 and PFOS – Impact of the Carcinogenic Finding On Businesses CMBG3 Law
Nov
13
2023
PFAS State AG Lawsuits Update: Delaware Enters the Fray CMBG3 Law
Jun
30
2022
How the Pharmacy Audit Appeals Process Works Oberheiden P.C.
Feb
22
2024
A Guide for FDA Whistleblowers Oberheiden P.C.
May
1
2023
Get Ready for FDA Investigations Over Semaglutide Oberheiden P.C.
Jun
17
2021
10 Provisions and 5 Steps to Electronic Prescription Compliance for Pharmacies Oberheiden P.C.
Sep
15
2022
Defense Strategies and FAQs if Your Board of Pharmacy is Investigating You Oberheiden P.C.
Aug
13
2021
5 Keys to Passing an FDA Inspection or Audit Oberheiden P.C.
Apr
29
2022
How Pharmacies Can Defend Against PBM Audits Oberheiden P.C.
Nov
13
2020
Pharmacy Compliance: What Do You Need to Know? Oberheiden P.C.
Jun
24
2021
12 Compliance Priorities for Clinical Laboratories that Bill Medicare, Medicaid, or Tricare Oberheiden P.C.
Jan
14
2022
Amniotic Fluid Injections Are at the Center of the Federal Government’s New Enforcement Effort Oberheiden P.C.
Feb
17
2022
Federal Criminal Drug Counterfeiting Defense Oberheiden P.C.
Sep
2
2021
7 Things To Do (and 7 Not To Do) During an FDA Investigation Oberheiden P.C.
Jan
19
2022
Coffee Burn Injury Lawsuits Buckfire Law
Mar
2
2022
Similac Baby Formula Recall & Enfamil and Similac Formula Lawsuits Buckfire Law
Jun
28
2021
Belviq Cancer Lawsuits Buckfire Law
Jul
18
2022
Camp Lejeune Water Contamination Lawsuits Buckfire Law
Nov
9
2022
Tylenol and Autism and ADHD Lawsuits Buckfire Law
Sep
1
2022
Wendy’s E. Coli Outbreak Lawsuits Buckfire Law
Apr
26
2022
What Municipalities Need to Know in 2022: Newly Signed Pennsylvania Legislation Strassburger McKenna Gutnick & Gefsky
Apr
8
2022
ICYMI: US House Passes Recreational Marijuana Bill Strassburger McKenna Gutnick & Gefsky
May
28
2021
CBD Here, CBD There, CBD Everywhere: Tension Between State and Federal Authorities Leaves CBD Companies in Limbo Strassburger McKenna Gutnick & Gefsky
Jul
18
2023
Report: Digital Health in India in 2023 Nishith Desai Associates
Dec
25
2020
Intellectual Property Issues in the Indian Pharmaceutical Sector: Patents Nishith Desai Associates
Dec
21
2020
Launching a Drug or Medical Device in India: From Clinical Trial to Sale [PODCAST} Nishith Desai Associates
Dec
27
2020
Digital Health in India: Emerging Technologies (AI and 3D printing) [Podcast] Nishith Desai Associates
 

NLR Logo

We collaborate with the world's leading lawyers to deliver news tailored for you. Sign Up to receive our free e-Newsbulletins

 

Sign Up for e-NewsBulletins